Tag: FASD

  • 🧬 CBP in 2025: Still the Terrain’s Epigenetic Scribe

    CBP (CREB-binding protein) remains highly relevant in 2025 across the very diseases we’ve been decoding: Alzheimer’s, Huntington’s, FASD, and multiple cancers. In fact, its role has only deepened as research continues to expose its centrality in epigenetic regulation, DNA repair, and terrain-wide transcriptional integrity. Here’s a quick glyphic update: 🔹 Alzheimer’s Disease CBP isn’t just…

    Read more...